Analgesic Effect of IntraPeritoneal LIGNOcaine in Gynaecological Open Surgery
Launched by UNIVERSITY OF MALAYA · May 31, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a local anesthetic called lignocaine when it is placed directly inside the abdominal cavity of women undergoing gynecological open surgery, such as cystectomy or hysterectomy. The goal is to see if this method can reduce postoperative pain more effectively than traditional pain relief methods, which often involve medications like morphine that can cause side effects such as nausea and dizziness. By using lignocaine directly in the area where surgery takes place, researchers hope to minimize pain and improve recovery times.
To participate in this study, women aged 18 to 60 who are scheduled for gynecological open surgery may be eligible, as long as they do not have certain health issues like allergies to lignocaine or severe heart and liver conditions. Participants will receive the study treatment and will be monitored for pain relief and any side effects. This research is important because it aims to improve pain management after surgery, helping patients recover more quickly and comfortably.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all adult women (American Society of Anesthesiologists (ASA) who \>18 years old and \<60 years old
- • gynaecological open surgery with midline or transverse laparotomy incision (below or above umbilicus)
- Exclusion Criteria:
- • laparoscopic surgery
- • allergic to lignocaine
- • history of cardiac, vascular or liver disease
- • ASA 3-5 or
- • body mass index \<18/ or \>40
About University Of Malaya
The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, , Malaysia
Patients applied
Trial Officials
Pui San Loh, MBBS
Principal Investigator
University of Malaya
Ka Ting Ng, MBChB
Principal Investigator
University of Malaya
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported